Dark

MLYS
Mineralys Therapeutics, Inc. Common Stock
stock NASDAQ

At Close

Jun 12, 2026 3:59:54 PM EDT

23.59USD-1.462%(-0.35)1,798,007

20.45Bid 27.25Ask 6.80Spread

Pre-market

Jun 9, 2026 9:27:30 AM EDT

23.12USD-3.425%(-0.82)0

After-hours

Jun 12, 2026 4:00:30 PM EDT

23.62USD+0.127%(+0.03)147,641

OverviewOptionsHistoricalExchangesShortsTrends

open chart

Market Cap

2.08B

Industry

Biotechnology

MLYS Stats

Avg. Vol. 10 Day

2,540,003

Avg. Vol. 30 Day

1,664,830

Employees

Market Cap

2,081,421,689

Shares Out.

88,158,479

On/Off Exchange

51%/49%

6 Month Beta

1.78

1 Year Beta

0.93

2 Year Beta

0.81

3 Year Beta

0.96

52 Week Low

12.59

52 Week High

47.65

SMA50

27.92

SMA200

32.94

1 Week

-0.34%

1 Month

-19.31%

3 Month

-12.52%

6 Month

-36.02%

1 Year

+58.24%

2 Year

+87.38%

5 Year

+28.04%

Profile

at mineralys therapeutics we aim to redefine hypertension diagnosis, management and treatment. we are driven to break the "trial and failure" approach to hypertension management and bring a personalized approach to the management of hypertension.

MLYS Stock Summary

Mineralys Therapeutics, Inc. Common Stock (NASDAQ:MLYS) stock price today is $23.59, and today's volume is 1,798,007. MLYS is down -1.462% today. The 30 day average volume is 1,664,830. MLYS market cap is 2.08B with 88,158,479 shares outstanding.

.dark-mode .sbWdzT{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .sbWdzT{ color: #333333; background-color: white; border: 2px solid #333333; }MLYSMineralys Therapeutics, Inc. Common Stockstock NASDAQ

MLYS Stock Summary

MLYS
Mineralys Therapeutics, Inc. Common Stock
stock NASDAQ